Documenting Receipt and Accountability of IP at Patient Homes in Decentralized Trials
Documenting Receipt and Accountability of IP at Patient Homes in Decentralized Trials How to Document Receipt and Accountability of Investigational Products at Patient Homes Decentralized Clinical Trials (DCTs) are increasingly relying on Direct-to-Patient (DTP) drug delivery models, which pose new challenges in maintaining compliance, patient safety, and investigational product (IP) traceability. Documenting the receipt and…
Read More “Documenting Receipt and Accountability of IP at Patient Homes in Decentralized Trials” »